Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study by Anthony Attia Edinburgh Medical School and colleagues thelancet.com/journals/lanhl…

New podcast online🎙️

We spoke to Nuru Noor about the genesis and findings of the PROFILE RCT (PROFILE Crohn's Trial), which found a benefit of very early treatment with combined anti-TNF & immunomodulator in #Crohns disease

Listen🔊buzzsprout.com/1728646/150235…

📜thelancet.com/journals/langa…

The latest issue of The Lancet Gastroenterology & Hepatology is out now!

A summary of content 👉linkedin.com/posts/rob-brie…

#GITwitter #LiverTwitter

Our June issue is out now at thelancet.com/gastrohep!

Content: management of IBS, loss of response to anti-TNF in Crohn’s, HCC surveillance in Africa, the environmental impact of gastroenterology, liver transplant for ACLF, MASLD, viral hepatitis + more

#GITwitter #LiverTwitter

New research - Wankhede et al - Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis

thelancet.com/journals/langa…

#GITwitter #CRCSM OncoAlert

Low anti-TNF concentrations at week 14 linked to long-term loss of response in Crohn’s healio.com/news/gastroent… via Healio Gastroenterology

New research - Miethke et al - Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

thelancet.com/journals/langa…

#PFIC #GITwitter

ICYMI, in our latest issue, the results of the PANDORINA trial, examining the role of prophylactic abdominal drainage after distal pancreatectomy

thelancet.com/journals/langa…

#GITwitter #SoMe4HPB

Recently in The Lancet Gastroenterology & Hepatology: head-to-head comparisons of diets and medical therapy for IBS + a new drug for Alagille syndrome

A summary 👉linkedin.com/posts/rob-brie…

#GITwitter #LiverTwitter

Rare & severe AEs in children w/ inflammatory bowel disease

Data from PIBD-SETQuality Safety Registry

Incidence per 10 000 p-y:
👉VTEs 5·50 (95% CI 4·25–6·97)
👉Renal failure 3·75 (2·74–4·99)
👉Opportunistic infection 3·67 (2·67–4·89)
👉Cancer 2·88 (2·01–3·98)

#GITwitter #IBD

Our May issue is out now: thelancet.com/journals/lanon…

In this issue, we publish articles on cancer in the prison population, #biliarytractcancer , #breastcancer , cabozantinib in #rarecancers , #COVID19 , #prostatecancer , #cancerscreening , and more

New Review - Napolitano et al - Targeting the EGFR signalling pathway in metastatic colorectal cancer

thelancet.com/journals/langa…

#CRCSM #OncTwitter #GITwitter

News - Scottish Parliament votes to increase minimum unit price for alcohol

thelancet.com/journals/langa…

#LiverTwitter #Alcohol Udani

U.S. Lags Behind Other Countries in Hepatitis-C Treatment nytimes.com/2024/04/28/hea… via The New York Times #NoHep #LiverTwitter

Dietary Interventions Beat Medication in IBS Treatment medpagetoday.com/gastroenterolo… via MedPage Today #GITwitter #IBS

Dietary interventions a promising first line treatment for IBS: thelimbic.com/gastroenterolo… via the limbic #GITwitter

New research - Ovchinsky et al - Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial

thelancet.com/journals/langa…

#LiverTwitter

New podcast online🎙️

Can we simplify #hepatitisB treatment eligibility in sub-Saharan African settings?

We spoke to Yusuke Shimakawa about work on a new treatment eligibility score to decentralise #hepatitisB care
🔊buzzsprout.com/1728646/149318…
📜thelancet.com/journals/langa…

Am extremely important editorial #Eliminate #ViralHepatitis NOhep Hep B Foundation World Hepatitis Alliance ICE-HBV

New Editorial - Urgent action needed to achieve viral hepatitis elimination

thelancet.com/journals/langa…

#NoHep #LiverTwitter